Cytokine Removal and Immunomodulation in COVID-19 Severe Pulmonary Respiratory Infection

Coronavirus infection produces a cytokine storm in some patients, developing a moderate to severe clinical condition that is associated to increased mortality mainly because of severe pulmonary involvement. Elevated levels of IL-6 have been found in non-survivor patients.

In these patients, clearance of cytokines with extracorporeal therapies, Pulse High- Volume Hemofiltration together with adsorption columns Cytosorb, in short periods of time for 1 to 3 days, could help remove inflammatory cytokines allowing a downregulation of the inflammatory response; and, at the same time, treatment with low dose steroids, could give an opportunity for the host to reach homeostasis, decreasing lung damage and improving survival.

Content

Author and article information

Journal

Title: ScienceOpen Preprints

Publisher: ScienceOpen

Publication date (Electronic preprint): 17 April 2020

Affiliations

[1 ] Instituto de Ciencias Médicas, Nefrología;

[2 ] Instituto de Ciencias Médicas, Infectología;

Author notes

[* ]Email: kavac7@ 123456gmail.com .

Author information

Karen Courville https://orcid.org/0000-0002-4182-6736

Maydelin Pecchio https://orcid.org/0000-0002-6322-5034

Article

DOI: 10.14293/S2199-1006.1.SOR-.PPWLC61.v1

SO-VID: 87ca94ec-18e4-4f95-967e-a025c3fab240

License:

This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

History

Date received : 17 April 2020

Funding

Funded by: funder-id , None;

Award ID: No Grants were used for this investigation

Comments

Alfonso Cueto-Manzano wrote:

This is an interesting review on this novel approach to counteract the cytokine storm produced by coronavirus infection.

The manuscript describes what is known about pathophysiology of pulmonar damage and propose novel treatment modalities. As these therapies already have a place in the treatment of kidney failure, from my point of view, mentioning kidney damage, frequently observed in coronavirus infection, would help to increase the interest for this manuscript.

Undoubtely, there is much to know about this disease, and the intense investigation, which is being performed about it, will give us many answers in the near future. Meanwhile, it is possible that therapeutic approaches such as proposed in this study, would help to save lifes, and are worth to take in account.

2020-05-10 18:47 UTC